Literature DB >> 11906549

c-myc gene amplification detected in preinvasive intraepithelial cervical lesions.

C D Golijow1, M C Abba, S A Mourón, M A Gómez, F N Dulout.   

Abstract

The aim of the present work was to evaluate the c-myc gene amplification process in cervical samples and to analyze the relationship between the activation of this proto-oncogene and the cytologic and/or histologic status. Thirty-four normal cervical samples and 105 abnormal cervical tissue scrapes, previously used for PAP or histopathologic diagnosis, were analyzed for c-myc gene amplification. Detection of c-myc gene amplification was performed using a polymerase chain reaction (PCR)-based method known as target arbitrarily primed-PCR (TAP-PCR). For c-myc amplification, significant differences were found between normal samples and samples presenting different grades of lesions (P<0.001). A significant difference between high-grade squamous intraepithelial lesions (HG-SIL) and the other stages of cervical disease was also found (P<0.05). This study demonstrated that c-myc copy number increases according to the histologic grade of the lesion. These results could indicate that oncogene amplification takes place in preinvasive stages of cervical disease and could cooperate not only in tumor progression but also in cell transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11906549     DOI: 10.1046/j.1525-1438.2001.01063.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Early detection of cervical carcinomas: finding an overall approach.

Authors:  Nicolas Wentzensen; Stefanie J Klug
Journal:  Dtsch Arztebl Int       Date:  2008-09-12       Impact factor: 5.594

2.  Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.

Authors:  Petr Kuglik; Jan Smetana; Vladimira Vallova; Lucie Moukova; Katerina Kasikova; Michaela Cvanova; Lucie Brozova
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

3.  Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions.

Authors:  Z Protrka; S Arsenijevic; A Dimitrijevic; S Mitrovic; V Stankovic; M Milosavljevic; T Kastratovic; J Djuric
Journal:  Eur J Histochem       Date:  2011-03-16       Impact factor: 3.188

4.  c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia.

Authors:  Kirsten Kübler; Sally Heinenberg; Christian Rudlowski; Mignon-Denise Keyver-Paik; Alina Abramian; Sabine Merkelbach-Bruse; Reinhard Büttner; Walther Kuhn; Hans-Ulrich Schildhaus
Journal:  Oncotarget       Date:  2015-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.